MAVIRET

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug MAVIRET contains a combination of these active pharmaceutical ingredients (APIs):

1	Glecaprevir UNII K6BUU8J72P - GLECAPREVIR
	Read more about Glecaprevir
2	Pibrentasvir UNII 2WU922TK3L - PIBRENTASVIR
	Pibrentasvir is a pan-genotypic inhibitor of HCV nonstructural protein 5A (NS5A), which is essential for viral RNA replication and virion assembly.
	Read more about Pibrentasvir

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MAVIRET Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AP57		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AP Antivirals for treatment of HCV infections
Discover more medicines within J05AP57

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11332K, 11333L, 11337Q, 11344C, 11345D, 11346E, 11353M, 11354N, 11355P
BR	Câmara de Regulação do Mercado de Medicamentos	543718050003302
CA	Health Products and Food Branch	02467550
EE	Ravimiamet	1751037, 1852860, 1860016
ES	Centro de información online de medicamentos de la AEMPS	1171213001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	071635, 436586
FR	Base de données publique des médicaments	63052124
GB	Medicines & Healthcare Products Regulatory Agency	346924
HK	Department of Health Drug Office	65653
IL	מִשְׂרַד הַבְּרִיאוּת	8348
IT	Agenzia del Farmaco	045445018, 045445032
JP	医薬品医療機器総合機構	6250113D1020, 6250113F1021
LT	Valstybinė vaistų kontrolės tarnyba	1083656, 1093263
NZ	Medicines and Medical Devices Safety Authority	18901
PL	Rejestru Produktów Leczniczych	100392356, 100458876
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65905001
SG	Health Sciences Authority	15603P
TR	İlaç ve Tıbbi Cihaz Kurumu	8680656080506